Impact of specialist care in patients with newly diagnosed heart failure
| ISRCTN | ISRCTN16302432 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16302432 |
| Secondary identifying numbers | N/A |
- Submission date
- 20/07/2005
- Registration date
- 07/09/2005
- Last edited
- 08/09/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr John Walsh
Scientific
Scientific
Department of Cardiovascular Medicine
Queens Medical Centre University Hospital
Nottingham
NG7 2UH
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Impact of specialist care in patients with newly diagnosed heart failure: a randomised controlled study |
| Study objectives | Out patients with newly diagnosed heart failure are managed more effectively when treated by specialists. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Heart failure |
| Intervention | Management in a specialist heart failure clinic with regular follow up by heart failure nurses versus usual care. All patients were followed up for a minimum of 3 months post-randomisation with a mean follow-up time of 10+/-3 months |
| Intervention type | Other |
| Primary outcome measure | Optimum prescription of medication for heart failure including angiotensin-converting enzyme (ACE) inhibitors, Angiotensin receptor blockers, beta blockers and spironolactone. |
| Secondary outcome measures | Composite endpoint of all cause mortality and/or hospitalisation. |
| Overall study start date | 06/06/2002 |
| Completion date | 06/09/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 114 patients |
| Key inclusion criteria | Patients (adults, either sex) with suspected heart failure referred for an open access echocardiogram. |
| Key exclusion criteria | Patients with previously confirmed left ventricular systolic dysfunction on echo. |
| Date of first enrolment | 06/06/2002 |
| Date of final enrolment | 06/09/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Cardiovascular Medicine
Nottingham
NG7 2UH
United Kingdom
NG7 2UH
United Kingdom
Sponsor information
Queens Medical Centre University Hospital (UK)
University/education
University/education
Department of Cardiovascular Medicine
Nottingham
NG7 2UH
England
United Kingdom
| Website | http://www.nuh.nhs.uk/ |
|---|---|
"ROR" |
https://ror.org/03ap6wx93 |
Funders
Funder type
Government
Local Delivery Plan for Heart Failure services in Nottingham (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 07/02/2007 | Yes | No |
